Zacks Research Comments on TriMas’ Q1 Earnings (NASDAQ:TRS)

TriMas Co. (NASDAQ:TRS) – Equities researchers at Zacks Research lowered their Q1 2025 earnings per share (EPS) estimates for shares of TriMas in a research report issued on Monday, March 10th. Zacks Research analyst M. Das now anticipates that the industrial products company will earn $0.43 per share for the quarter, down from their prior forecast of $0.44. The consensus estimate for TriMas’ current full-year earnings is $1.69 per share. Zacks Research also issued estimates for TriMas’ Q1 2026 earnings at $0.47 EPS and FY2027 earnings at $2.18 EPS.

Separately, BWS Financial restated a “buy” rating and set a $40.00 price objective on shares of TriMas in a research note on Friday, February 28th.

TriMas Trading Down 1.9 %

Shares of NASDAQ TRS opened at $23.99 on Wednesday. The company has a debt-to-equity ratio of 0.60, a current ratio of 2.83 and a quick ratio of 1.44. The stock has a market capitalization of $973.59 million, a P/E ratio of 37.48 and a beta of 0.65. TriMas has a 1-year low of $19.33 and a 1-year high of $28.51. The business has a fifty day moving average price of $23.56 and a 200 day moving average price of $25.05.

TriMas Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Friday, March 7th. Investors of record on Friday, February 28th were paid a dividend of $0.04 per share. This represents a $0.16 dividend on an annualized basis and a dividend yield of 0.67%. The ex-dividend date of this dividend was Friday, February 28th. TriMas’s dividend payout ratio (DPR) is currently 27.12%.

Insider Buying and Selling

In other TriMas news, Director Shawn Sedaghat purchased 554,149 shares of the firm’s stock in a transaction on Monday, March 10th. The stock was bought at an average cost of $24.07 per share, for a total transaction of $13,338,366.43. Following the completion of the purchase, the director now owns 900,974 shares in the company, valued at $21,686,444.18. This represents a 159.78 % increase in their position. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, CFO Scott A. Mell sold 2,218 shares of the stock in a transaction dated Thursday, March 6th. The shares were sold at an average price of $22.54, for a total value of $49,993.72. Following the completion of the sale, the chief financial officer now owns 26,288 shares of the company’s stock, valued at approximately $592,531.52. This trade represents a 7.78 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders purchased 806,246 shares of company stock worth $19,338,213 in the last three months. 1.10% of the stock is owned by insiders.

Institutional Investors Weigh In On TriMas

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in the business. Bank of America Corp DE increased its holdings in shares of TriMas by 127.3% in the fourth quarter. Bank of America Corp DE now owns 3,513,638 shares of the industrial products company’s stock valued at $86,400,000 after purchasing an additional 1,967,738 shares during the period. Bellecapital International Ltd. acquired a new stake in TriMas during the fourth quarter worth about $29,160,000. Impax Asset Management Group plc grew its holdings in TriMas by 216.4% during the third quarter. Impax Asset Management Group plc now owns 410,000 shares of the industrial products company’s stock worth $10,467,000 after acquiring an additional 280,431 shares during the period. Raymond James Financial Inc. acquired a new stake in TriMas during the fourth quarter worth about $6,698,000. Finally, Wellington Management Group LLP grew its holdings in TriMas by 10.7% during the third quarter. Wellington Management Group LLP now owns 2,619,359 shares of the industrial products company’s stock worth $66,872,000 after acquiring an additional 252,537 shares during the period. 99.42% of the stock is currently owned by hedge funds and other institutional investors.

TriMas Company Profile

TriMas Corporation engages in the design, development, manufacture, and sale of products for consumer products, aerospace, and industrial markets worldwide. The company operates through Packaging, Aerospace, and Specialty Products segments. The Packaging segment offers dispensing products, such as foaming and sanitizer pumps, lotion and hand soap pumps, beverage dispensers, perfume sprayers, and nasal and trigger sprayers; polymeric and steel caps and closures comprising food lids, flip-top and beverage closures, child resistance caps, drum and pail closures, and flexible spouts; polymeric jar products; integrated dispensers; bag-in-box products; and consumable vascular delivery and diagnostic test components under the Rieke, Taplast, Affaba & Ferrari, Intertech, Omega, and Rapak brands.